Update on Capacity Addition at the Subsidiary.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rossari Biotech's material subsidiary, Unitop Chemicals, has commissioned the remaining 15,000 MTPA (metric tonnes per annum) of ethoxylation capacity at its Dahej facility, effective March 31, 2026. This completes the previously announced 30,000 MTPA expansion plan, taking Unitop's total installed ethoxylation capacity to 66,000 MTPA. The company had been updating the exchanges about this phased expansion since October 2023, and the final leg has now been successfully delivered. No financial details on the capex spend or expected revenue impact were disclosed in this filing.
This is a positive operational milestone for Rossari Biotech, expanding the production capacity of its subsidiary and potentially supporting higher future revenues. The phased execution appears on track, which should reassure investors about the company's project delivery capabilities, though the stock reaction may be limited as no incremental financial guidance was provided.